Professor Sunil Lakhani is the Chair of the BCT Board of Directors. He is a clinical diagnostic pathologist and also heads a research team comprising scientists and clinicians, ensuring a translational focus to the program.
We spoke with him about Ductal Carcinoma in Situ, and how it relates to breast cancer.
